tisagenlecleucel (Kymriah) Report issue

Cell therapy Orphan Drug FDA Approved FDA Breakthrough Therapy FDA
AACT
Back

Drug Pricing Summary

VA Big4

$28355.5920 - $36096.3130

VA FSS

$37217.5280 - $47394.9750

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
tisagenlecleucel 2000000 (INJECTION) $36096.3130 VA Big4
  • KYMRIAH (10)
    		•  Novartis Pharmaceuticals Corporation
    tisagenlecleucel 2000000 (INJECTION) $47394.9750 VA FSS
  • KYMRIAH (10)
    		•  Novartis Pharmaceuticals Corporation
    tisagenlecleucel 60000000 (INJECTION) $28355.5920 VA Big4
  • KYMRIAH (10)
    		•  Novartis Pharmaceuticals Corporation
    tisagenlecleucel 60000000 (INJECTION) $37217.5280 VA FSS
  • KYMRIAH (10)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue